Use of Coronary Computed Tomographic Angiography to Guide Management of Patients With Coronary Disease

[1]  Scot-Heart Investigators,et al.  CT coronary angiography in patients with suspected angina due to coronary heart disease (SCOT-HEART): an open-label, parallel-group, multicentre trial , 2015, The Lancet.

[2]  P. Douglas.  The theory and practice of imaging outcomes research , 2015, The Lancet.

[3]  Y. Yoon,et al.  Association between Aspirin Therapy and Clinical Outcomes in Patients with Non-Obstructive Coronary Artery Disease: A Cohort Study , 2015, PloS one.

[4]  E. V. van Beek,et al.  Observer variability in the assessment of CT coronary angiography and coronary artery calcium score: substudy of the Scottish COmputed Tomography of the HEART (SCOT-HEART) trial , 2015, Open Heart.

[5]  Y. Yoon,et al.  Statin therapy is associated with lower all-cause mortality in patients with non-obstructive coronary artery disease. , 2015, Atherosclerosis.

[6]  D. Berman,et al.  Prognostic and Therapeutic Implications of Statin and Aspirin Therapy in Individuals With Nonobstructive Coronary Artery Disease: Results From the CONFIRM (Coronary CT Angiography Evaluation For Clinical Outcomes: An International Multicenter Registry) Registry , 2015, Arteriosclerosis, thrombosis, and vascular biology.

[7]  D. Berman,et al.  Incremental prognostic utility of coronary CT angiography for asymptomatic patients based upon extent and severity of coronary artery calcium: results from the COronary CT Angiography EvaluatioN For Clinical Outcomes InteRnational Multicenter (CONFIRM) study. , 2015, European heart journal.

[8]  R. Blankstein,et al.  Coronary Artery Disease Detected by Coronary Computed Tomographic Angiography Is Associated With Intensification of Preventive Medical Therapy and Lower Low-Density Lipoprotein Cholesterol , 2014, Circulation. Cardiovascular imaging.

[9]  Jeroen J. Bax,et al.  2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. , 2013, European heart journal.

[10]  T. Villines,et al.  Changes in preventive medical therapies and CV risk factors after CT angiography. , 2013, JACC. Cardiovascular imaging.

[11]  Sankey V. Williams,et al.  2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Ass , 2012, Journal of the American College of Cardiology.

[12]  Colin Berry,et al.  Role of multidetector computed tomography in the diagnosis and management of patients attending the rapid access chest pain clinic, The Scottish computed tomography of the heart (SCOT-HEART) trial: study protocol for randomized controlled trial , 2012, Trials.

[13]  J. J. Rivera,et al.  Impact of coronary computed tomographic angiography results on patient and physician behavior in a low-risk population. , 2011, Archives of internal medicine.

[14]  D. Newby,et al.  Implementation of a sensitive troponin I assay and risk of recurrent myocardial infarction and death in patients with suspected acute coronary syndrome. , 2011, JAMA.

[15]  F. Lin,et al.  Impact of coronary computed tomographic angiography findings on the medical treatment and control of coronary artery disease and its risk factors. , 2009, The American journal of cardiology.

[16]  R. Blumenthal,et al.  Effect of patient visualization of coronary calcium by electron beam computed tomography on changes in beneficial lifestyle behaviors. , 2008, The American journal of cardiology.

[17]  Jeroen J. Bax,et al.  Cardiac computed tomography: indications, applications, limitations, and training requirements: report of a Writing Group deployed by the Working Group Nuclear Cardiology and Cardiac CT of the European Society of Cardiology and the European Council of Nuclear Cardiology. , 2008, European heart journal.

[18]  R. Collins,et al.  Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins , 2005, The Lancet.

[19]  K. Fox,et al.  Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: the British Heart Foundation RITA 3 randomised trial , 2002, The Lancet.

[20]  T. Shaw,et al.  Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: the British Heart Foundation RITA 3 randomised trial. Randomized Intervention Trial of unstable Angina. , 2002, Lancet.

[21]  A. Connor,et al.  The way I see it: House officers need formal career development , 2002 .

[22]  A. Mattioli,et al.  Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients , 2002, BMJ : British Medical Journal.

[23]  J. Pogue,et al.  Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. , 2000, The New England journal of medicine.

[24]  D. Wood,et al.  Incidence, clinical characteristics, and short-term prognosis of angina pectoris. , 1995, British heart journal.

[25]  Scandinavian Simvastatin Survival Study Group.  Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) , 1994, The Lancet.

[26]  J. Slattery,et al.  Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). 1994. , 1994, Atherosclerosis. Supplements.

[27]  T. Chalmers,et al.  Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration , 1994, The Lancet.

[28]  J. Stengård,et al.  Antibodies to glutamic acid decarboxylase as predictors of insulin-dependent diabetes mellitus before clinical onset of disease , 1994, The Lancet.

[29]  C. Madden.  Risk of myocardial infarction and death during treatment with low dose aspirin and intravenous heparin in men with unstable coronary artery disease: The RISC Group Lancet 336: 827–830 Oct 1990 , 1991 .

[30]  S. Malhotra,et al.  A selection of recent, original research papers , 2015, Journal of Nuclear Cardiology.

[31]  B. Gersh,et al.  ESC guidelines on the management of stable coronary artery disease — addenda The Task Force on the management of stable coronary artery disease of the European Society of Cardiology , 2013 .

[32]  S. Abbara.  Diagnostic Performance of Coronary Angiography by 64-Row CT , 2009 .